PE101: Introduction to Patient Engagement in Health ResearchCHICommunications
Beginner level introduction to the underlying principles and concepts required for meaningful patient and public engagement.
Following this session, attendees should be able to:
Describe theoretical and practical principles of inclusive, authentic, and meaningful engagement of people with lived experience in health research;
Access resources to improve their knowledge of patient and public engagement practices; and
Participate in intermediate level PE Lunchtime Learning sessions.
This case study by PREPPP Award winner Dr. Anna Chudyk and her team discusses experiences, lessons learned, and barriers and facilitators to engaging in health research scoping reviews.
Considering applying for CHI's Preparing for Research by Engaging Patient and Public Partners (PREPPP) Award? Check out this slide deck of tips & suggestions for your application.
More info at www.chimb.ca/preppp
Learn about considerations when budgeting for patient and public engagement, and use of CHI's PE budgeting tool when applying for funding.
About this session
CHI's Lunchtime Learning is open to all researchers, decision-makers, clinicians, patients and members of the public who want to learn more about the theory and practice of meaningful, inclusive, and safe patient and public engagement.
Following this session, attendees should be able to:
• Identify key considerations when budgeting for patient engagement;
• Access and use CHI's Patient Engagement Budgeting Tool; and
• Develop a draft budget that can be attached to funding applications.
Efforts to place the patient at the center of medical research, spurred by the Affordable Care Act’s founding of the Patient Centered Outcomes Research Institute, have begun to change the way clinical research is conceptualized and conducted. Such efforts hold great promise, but also raise potential challenges for ethical oversight. How should oversight bodies approach the presence of patients in potentially unfamiliar research roles, such as investigator? What forms of patient involvement in research, if any, warrant increased scrutiny from oversight bodies? How do we keep the patient voice from being ‘captured’ by special interest groups? This symposium brought together a diverse group of patients and community members, policymakers, bioethicists, and regulatory officials to address these and other issues.
PE101: Introduction to Patient Engagement in Health ResearchCHICommunications
Beginner level introduction to the underlying principles and concepts required for meaningful patient and public engagement.
Following this session, attendees should be able to:
Describe theoretical and practical principles of inclusive, authentic, and meaningful engagement of people with lived experience in health research;
Access resources to improve their knowledge of patient and public engagement practices; and
Participate in intermediate level PE Lunchtime Learning sessions.
This case study by PREPPP Award winner Dr. Anna Chudyk and her team discusses experiences, lessons learned, and barriers and facilitators to engaging in health research scoping reviews.
Considering applying for CHI's Preparing for Research by Engaging Patient and Public Partners (PREPPP) Award? Check out this slide deck of tips & suggestions for your application.
More info at www.chimb.ca/preppp
Learn about considerations when budgeting for patient and public engagement, and use of CHI's PE budgeting tool when applying for funding.
About this session
CHI's Lunchtime Learning is open to all researchers, decision-makers, clinicians, patients and members of the public who want to learn more about the theory and practice of meaningful, inclusive, and safe patient and public engagement.
Following this session, attendees should be able to:
• Identify key considerations when budgeting for patient engagement;
• Access and use CHI's Patient Engagement Budgeting Tool; and
• Develop a draft budget that can be attached to funding applications.
Efforts to place the patient at the center of medical research, spurred by the Affordable Care Act’s founding of the Patient Centered Outcomes Research Institute, have begun to change the way clinical research is conceptualized and conducted. Such efforts hold great promise, but also raise potential challenges for ethical oversight. How should oversight bodies approach the presence of patients in potentially unfamiliar research roles, such as investigator? What forms of patient involvement in research, if any, warrant increased scrutiny from oversight bodies? How do we keep the patient voice from being ‘captured’ by special interest groups? This symposium brought together a diverse group of patients and community members, policymakers, bioethicists, and regulatory officials to address these and other issues.
Documenting Your Leadership/Administration Efforts In a Way that Countstatetomika
Learn more about documenting your leadership and administration efforts with Mayumi Nakagawa, MD, PhD
Professor of Pathology, College of Medicine
Co-Leader, Cancer Prevention and Population Sciences Program, Winthrop P. Rockefeller Cancer Institute
Drs. Mae and Anderson Nettleship Endowed Chair in Oncologic Pathology
UAMS
Documenting Your Clinical Efforts In a Way that Countstatetomika
Learn more about documenting your clinical efforts with Daniela A. Ochoa MD FACS Associate Professor Department of Surgery Division of Breast Oncology Winthrop P. Rockefeller Cancer Institute UAMS and Nirvana A. Manning MD FACOG
Associate Professor Chair, Department of Obstetrics and Gynecology Service Line Director of Women’s and Infants Service Line UAMS
Bringing the patient voice into GSK for educational, awareness and patient ce...Nowgen
"Bringing the patient voice into GlaxoSmithKline for educational, awareness and patient centred decisions within medicine development", presented by Kay Warner, Global Manager, Focus on the Patient, GlaxoSmithKline, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Patient Engagement in Health Economic and Outcomes Research: Current and Future ISPOR Initiatives, presentation from the ISPOR 20th International meeting Philadelphia, May 2015, by the Patient Centered Special Interest Group
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)Nowgen
"INVOLVE perspectives on learning and development", presented by Sarah Buckland, INVOLVE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...Nowgen
Involving People: Patients, Participants & Consumers in U.K.Cancer Research, presented by Richard Stephens at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
The following resource was developed by RESYST for a research uptake workshop held in Kilifi, Kenya.
In this resource:
- Understand the importance of strategic planning for research uptake
- Familiarise key aspects of a research uptake strategy
- Develop research uptake objectives for your research group, project, hub or an event
- Identify key stakeholders using stakeholder analysis techniques
- Review communications channels, outputs and activities
- Explore indicators and tools for monitoring and evaluation
- Key questions to consider in a research uptake strategy
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
Documenting Your Leadership/Administration Efforts In a Way that Countstatetomika
Learn more about documenting your leadership and administration efforts with Mayumi Nakagawa, MD, PhD
Professor of Pathology, College of Medicine
Co-Leader, Cancer Prevention and Population Sciences Program, Winthrop P. Rockefeller Cancer Institute
Drs. Mae and Anderson Nettleship Endowed Chair in Oncologic Pathology
UAMS
Documenting Your Clinical Efforts In a Way that Countstatetomika
Learn more about documenting your clinical efforts with Daniela A. Ochoa MD FACS Associate Professor Department of Surgery Division of Breast Oncology Winthrop P. Rockefeller Cancer Institute UAMS and Nirvana A. Manning MD FACOG
Associate Professor Chair, Department of Obstetrics and Gynecology Service Line Director of Women’s and Infants Service Line UAMS
Bringing the patient voice into GSK for educational, awareness and patient ce...Nowgen
"Bringing the patient voice into GlaxoSmithKline for educational, awareness and patient centred decisions within medicine development", presented by Kay Warner, Global Manager, Focus on the Patient, GlaxoSmithKline, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Patient Engagement in Health Economic and Outcomes Research: Current and Future ISPOR Initiatives, presentation from the ISPOR 20th International meeting Philadelphia, May 2015, by the Patient Centered Special Interest Group
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)Nowgen
"INVOLVE perspectives on learning and development", presented by Sarah Buckland, INVOLVE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...Nowgen
Involving People: Patients, Participants & Consumers in U.K.Cancer Research, presented by Richard Stephens at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
The following resource was developed by RESYST for a research uptake workshop held in Kilifi, Kenya.
In this resource:
- Understand the importance of strategic planning for research uptake
- Familiarise key aspects of a research uptake strategy
- Develop research uptake objectives for your research group, project, hub or an event
- Identify key stakeholders using stakeholder analysis techniques
- Review communications channels, outputs and activities
- Explore indicators and tools for monitoring and evaluation
- Key questions to consider in a research uptake strategy
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
Isn't this about me? The role of patients and the public in implementing evid...NEQOS
Master Class, led by Professor Richard Thomson- focusing on the role of patients and public in implementing evidence-based healthcare- including shared decision making
Maxime Lê is a graduate of health sciences from the University of Ottawa that has worn many hats for many roles. Chief among them is being a patient advisor for The Ottawa Hospital. Having frequently been a patient and having a passion for health and healthcare, he decided to get involved at The Ottawa Hospital to help improve care, research and advocate for patients. Maxime, while sharing his hands-on experience and insights, answered the questions that healthcare providers, researchers, or prospective patient advisors may have, such as: ''What does it mean to be a patient advisor?'', ''Why is it important?'', and ''What impact does it have?''.
The webinar was followed by an interactive question and answer session.
Dr Patricia Gillen presents at the Doctoral Midwifery Research Society Alcohol & Medication in Pregnancy Conferene about 'Public & Practioner Engagement & involvement in Health & Social Care Research: Theory & Practice'
Involving patients in research what have we done and how did we do it? Jean R. Slutsky, Patient-Centered Outcomes Research Institute (PCORI) Foredrag, Brukermedvirkning i helseforskning, fra ord til handling. Diakonhjemmet Sykehus 4. november 2014.
Patient Engagement Presentation - MPN Network Forum April 18, 2017Alexandra Enns
April 18, 2017
In April we held a Network Forum on engaging policymakers and patients/public effectively and appropriately. We would like to give a warm thanks to both Carolyn Shimmin, Patient Engagement expert of CHI's Knowledge Translation team, and Marcia Thomson, Assistant Deputy Minister of Manitoba Health, Seniors and Active Living for their presentations. Below you can see Carolyn's presentation - to see more of her work on patient engagement and to learn more about knowledge translation at CHI, please check out the blog Knowledge Nudge here. If you would like more information, helpful tools or advice about patient/public engagement in research, please contact Carolyn Shimmin at cshimmin@exchange.hsc.mb.ca
Better Healthcare Through Community and Stakeholder Engagement, 2015 Webinar ...Paul Gallant
"An enjoyable presentation, well-delivered with excellent insight into community and stakeholder engagement strategies. Terry Dyni - July 23, 2015" on the webinar version. This version is my complete slide deck from a live webinar presentation requested by the Conference Board of Canada. April, 2015. Thanks for your interest in Better Healthcare Through Community and Stakeholder Engagement.
Compliments of Paul W. Gallant, CHE, GALLANT HEALTHWORKS & Associates (GHWA), Vancouver, BC, Canada. PS See the last slide for contact details or to arrange customized training/facilitation or advice on your organizational needs.
Why Patient Engagement Matters in Data Science, Engineering and TechnologyCHICommunications
This presentation, delivered on February 28, 2024, discusses and defines patient-oriented research as it relates to the fields of data science, engineering and technology.
Participants also learned about CHI's annual Preparing for Research by Engaging Patient and Public Partners (PREPPP) award.
chimb.ca
Patient, carer & public involvement in clinical guidelines: the NICE experienceGuíaSalud
Presentación de Victoria Thomas, Associate Director, Patient & Public Involvement Programme de NICE, sobre la participación de pacientes, ciudadanos y público en general en el desarrollo de guías de práctica clínica del NICE. Ponencia realizada en la Jornada Científica GuíaSalud 2010 "La participación de los pacientes en las Guías de Práctica Clínica".
Patient Engagement for Data Science, Technology & EngineeringCHICommunications
Learn the necessities and relationship between patient engagement and data science, engineering and technology.
Presented by Trish Roche, CHI's Knowledge Translation Practice Lead, this presentation is geared towards professionals in data science looking to hone their skills in patient engagement.
Similar to Sabi Redwood: Patient and public involvement in applied health research (20)
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Sabi Redwood: Patient and public involvement in applied health research
1. Patient & public involvement in
applied health research
Sabi Redwood
PCCS / Collaborations in Leadership
in Applied Health Research and Care
2. What is PPI?
Ways in which patients can draw on their
experience and members of the public can apply
their priorities to research, and the
evaluation, development and organisation of
health and social services
– Patients/ service users as individuals
– Community organisations and carers on
behalf of others
– Members of communities, localities and the
general public
(Tritter 2009)
3. PPI as a mechanism for
• dialogue between different stakeholders in order
to the co-produce knowledge and services
• accountability to ensure local service meet the
needs of local communities and patients/ service
users
• for driving change in the culture of health and
social care services and redefining the
relationship between communities and the state
4. PPI in the research process
Identifying and
prioritising
Evaluation
Implementation
Dissemination of
research findings
Analysing and
interpreting the data
Design
Development of the grant
application
Undertaking and managing
the research
5. Identifying and prioritising
• Through local user groups and organisations
to help inform research priorities
• Consultation about research topics and
priorities, important to them as service users
• Collaboration with researchers to identify
topics for research
• User generated/ led topics for research
6. Design
• Clarify the research question and affirm its
importance/ relevance
• Ensure the methods selected are appropriate
for patients
• Assist in creating a recruitment strategy
• Review and comment on proposed data
collection methods
7. Development of the grant application
• Who/ why and how?
• Help to ensure that the research proposed and
chosen methods are acceptable/ ethical
• Define outcome measures
• Advise on the appropriateness of the lay
summary
• Raise awareness about costs of
involvement, expenses and prompt researchers
to cost for involvement
• Be named as co-applicants
8. Undertaking and managing the
research
• Part of steering group to manage / monitor
the research
• Assist in writing the patient information and
consent forms
• Produce research updates that are patient/ lay
friendly
• Can assist in conducting interviews and
surveys
9. Analysing and interpreting the data
• More appropriate for user led approaches
especially in relation to seldom heard groups
(for example sex workers)
• Assist the research team in developing themes
from data
• Consultation to verify research team’s
interpretation of data
10. Dissemination of research findings
• Advise on different avenues for disseminating
results
• Jointly present the findings with researchers
• Write information for local patient / groups
hospitals etc
• Assist in getting results / findings published on
charities / voluntary organisations websites
• Help distribute results within their information
networks
• Produce summaries of findings
11. Implementation
• Increase the likelihood that results of research
are implemented, by adding validity to the
findings
• Develop patient information for new services /
interventions within hospitals, GPs surgeries
etc
12. Evaluation
• Continued involvement with the study to
maintain focus and address issues as they
arise
• Collaborate with researchers to evaluate the
research process
13. Personal observations
• Political not just technical or procedural issue
• Requires supportive infrastructures
• No persuasive evidence that it leads to
‘better’ research, but maybe benefits are not
measurable
• Benefits to individual PPI partners not enough
• Importance of the move from individual story
to collective voice
14. Support for researchers
• Research Design Service
• INVOLVE publicly funded national advisory
group, which promotes and supports greater
public involvement in health research
• Development of local infrastructures – work in
progress